Monday, April 11, 2022

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

 The Microdose Plant Medicine Week will be held on April 5-8th 2022, at the Mediterranean Conference Centre, one of the finest heritage buildings of Valletta, Malta. The Centre is a landmark venue having membership of the prestigious Historic Conference Centres of Europe (“HCCE”). Investors, entrepreneurs, psychedelic and cannabis researchers, policymakers, and professionals from the health, legislation, and education fields are invited to attend the event. 

The agenda of the event focuses on the expansion of cannabis and psychedelic medicine usage and trade on the island and reviewing the existing laws and schemes to encourage cannabis investment opportunities in Malta. Knowledge and information sharing will be done through case studies, presentations, discussions, keynotes, and insights from industry leaders, researchers, and experts about the potential and scope of investments in the psychedelic sector. 

The Plant Medicine Week is well-curated by an expert team of professionals who have hosted numerous conferences in the cannabis and psychedelic medicine sector. They have partnered with the best hotels in the region to offer a comfortable stay to the attendees. 

This event is organized in two sections:

  • Cannabis Medicine – organized by – Medcann World Forum (April 5-6th 2022)-Influential industry leaders from Europe and all across the globe come together for a cannabis discussion on legislation, business, regulatory, education & research. They will further share insights on how new cannabis ventures and investments can find their way to Europe and the barriers of entry in Germany.
  • Psychedelic Medicine – (April 7-8th 2022)- organized by Microdose Psychedelic Insights a leading media company focused on organizing events on psychedelic medicine. Microdose hosts this conference to explore the immense scope of psychedelic investment, the laws.               

The Plant Medicine Week opens novel opportunities in the psychedelic investment sector for traders in and around the island. The event will feature discussions on the latest innovations in drug development, the laws and regulations that effect cannabis trade, public interest, and business trends that impact the support of laws surrounding cannabis use and trading. 

Tickets are available for either one or both of the events. Participants from all over the globe can also access the conference virtually. 

To learn more, please visit https://plantmedicineweek.com/.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

No comments:

Post a Comment